Human Epidermal Growth Factor Receptor 2–Targeting [(68)Ga]Ga-ABY-025 PET/CT Predicts Early Metabolic Response in Metastatic Breast Cancer

Imaging using the human epidermal growth factor receptor 2 (HER2)–binding tracer (68)Ga-labeled Z(HER2:2891)-Cys-MMA-DOTA ([(68)Ga]Ga-ABY-025) was shown to reflect HER2 status determined by immunohistochemistry and in situ hybridization in metastatic breast cancer (MBC). This single-center open-labe...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhuseinalkhudhur, Ali, Lindman, Henrik, Liss, Per, Sundin, Tora, Frejd, Fredrik Y., Hartman, Johan, Iyer, Victor, Feldwisch, Joachim, Lubberink, Mark, Rönnlund, Caroline, Tolmachev, Vladimir, Velikyan, Irina, Sörensen, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2023
Materias:
Featured Article of the Month
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478820/
https://www.ncbi.nlm.nih.gov/pubmed/37442602
http://dx.doi.org/10.2967/jnumed.122.265364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478820/
https://www.ncbi.nlm.nih.gov/pubmed/37442602
http://dx.doi.org/10.2967/jnumed.122.265364

Ejemplares similares